Correlation Between Tscan Therapeutics and Exagen

Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tscan Therapeutics and Exagen Inc, you can compare the effects of market volatilities on Tscan Therapeutics and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Exagen.

Diversification Opportunities for Tscan Therapeutics and Exagen

0.32

Correlation Coefficient

Tscan Therapeutics  Exagen

Weak diversification

The 3 months correlation between Tscan and Exagen is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Exagen go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and Exagen

Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 1.51 times less return on investment than Exagen. In addition to that, Tscan Therapeutics is 1.43 times more volatile than Exagen Inc. It trades about 0.12 of its total potential returns per unit of risk. Exagen Inc is currently generating about 0.25 per unit of volatility. If you would invest  699.00  in Exagen Inc on July 1, 2025 and sell it today you would earn a total of  390.00  from holding Exagen Inc or generate 55.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Tscan Therapeutics  vs.  Exagen Inc

Tscan Therapeutics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Tscan Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Tscan Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Exagen Inc

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Tscan Therapeutics and Exagen

The main advantage of trading using opposite Tscan Therapeutics and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.

The idea behind Tscan Therapeutics and Exagen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.